Microbot Medical Inc.
NASDAQ:MBOTMedical - Instruments & Supplies
-$0.06 today
- Market cap
- $65.73M
- Beta
- 1.04
- P/E (TTM)
- -8.6
- EPS (TTM)
- -$0.21
Volume 0.87M
Average 1.60M
MBOT Net Debt
Total debt minus cash and equivalents; a negative value means the company holds more cash than debt.
Microbot Medical Inc.NASDAQ: MBOT
Net Debt · Q1 FY2026 · quarter ended Mar 2026
Net debt remains negative
Q1 FY2026 net debt was -$2.76M, compared with -$3.08M a year earlier.
Context
- Net debt amounted to 3.5% of total assets at the end of Q1 FY2026, down 6.4 pp from a year earlier.
- Net debt grew in size in 3 of the last 3 fiscal years.
- FY2025 was the largest annual figure in the 4 fiscal years shown.
What to watch
Whether net debt keeps rising in the next quarterly balance sheet after a +10.4% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Net Debt history
USD · from the balance sheet
- Latest · FY2025
- (3.05M) USD
- Year-over-year change
- -1.5%
| Period | Period end | Net Debt | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (3.05M) | -1.5% |
| FY2024 | 2024-12-31 | (3M) | -34.2% |
| FY2023 | 2023-12-31 | (2.24M) | -8.8% |
| FY2022 | 2022-12-31 | (2.06M) | +83.9% |
| FY2021 | 2021-12-31 | (12.81M) | — |
Net Debt vs competitors
How MBOT compares with its peers on the latest reported figures
- Peers report in different currencies, so net debt is compared through growth and share of total assets rather than absolute size.
- Its year-over-year change of +10.4% is the 5th highest of 10, against a peer median of +9.5%.
- Net debt amounts to 3.5% of total assets for MBOT, versus a peer median of 12.3%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $16.11M USD | +45.0% | +6.9% | 74.4% | |
| Mar 2026 | CA$611.89K CAD | +9.5% | — | 4.0% | |
| Mar 2026 | -$1.47M USD | -124.8% | — | 3.5% | |
| Mar 2026 | -$2.76M USD | +10.4% | — | 3.5% | |
| Mar 2026 | -$6.33M USD | -121.7% | — | 12.3% | |
| Mar 2026 | -$7.17M USD | +60.5% | — | 3.4% | |
| Mar 2026 | -$12.44M USD | +83.2% | — | 4.6% | |
| Mar 2026 | -CA$27.63M CAD | -19.4% | — | 87.7% | |
| Mar 2026 | -$54.25M USD | +39.2% | — | 92.2% | |
| Mar 2026 | -$92.61M USD | -1280.9% | — | 41.0% | |
| Peer median (excluding MBOT) | — | +9.5% | +6.9% | 12.3% | |
Competitors are the stored peer set for MBOT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Microbot Medical Inc.
NASDAQ:MBOT
Intrinsic Alpha fair value
Locked
Current Price
$0.98
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.